United Kingdom Archives

News and Trends 11 Aug 2022

Acquisition of TeneoTwo and its clinical-stage T-cell engager completed

AstraZeneca has said today (August 11) that it has completed its purchase of TeneoTwo including its B-cell non-Hodgkin lymphoma drug candidate. The company made an upfront payment of $100 million and then additional payments of up to $805 million contingent on research and development milestones as well as up to $360 million to TeneoTwo’s former […]

August 11, 2022 - 2 minutesmins - By Liza Laws

Interview 10 Aug 2022

How the UK precision breeding bill could unshackle gene editing

The U.K. is considering lowering restrictions on gene-edited crops. PacBio’s Neil Ward explains how the changes could impact the gene editing landscape. CRISPR gene editing technology has changed the game in the biotech industry by making it easier than ever before to make small changes to the genome. In addition to myriad healthcare applications, the […]

August 10, 2022 - 6 minutesmins - By Jonathan Smith

News and Trends 10 Aug 2022

Research discovery may help diagnose and treat cancer and brain disorders

Researchers at Queen’s University Belfast in Northern Ireland have revealed how the pathway of an identified protein could lead to early diagnosis and targeted treatment for several cancers and brain disorders. The team of researchers discovered how the journey or molecular pathway of an identified protein is both essential for brain development and how an […]

August 10, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 9 Aug 2022

Start-up receives science and business support at Lab Hotel

Stevenage Bioscience Catalyst (SBC) has welcomed Inspira Pharmaceuticals to its Lab Hotel, a facility offering free lab and office accommodation for six months to start-ups. The start-ups receive scientific and business support, access to SBC’s networks and introductions to investors to help their business grow and develop. Biotech start-up Rory McGoldrick, co-founder and CEO of […]

August 9, 2022 - 2 minutesmins - By Liza Laws

News and Trends 4 Aug 2022

PolyPid to receive millions for commercialization of infection-fighting drug

A drug to prevent surgical site infections (SSIs) in abdominal and cardiac surgeries in Europe is to be commercialized after two companies entered an exclusive licensing agreement. Israel-based PolyPid Ltd and UK-based ADVANZ PHARMA Corp. announced the agreement for lead drug candidate D-PLEX100 yesterday (August 3). Topline results Under the terms of the agreement, PolyPid will receive […]

August 4, 2022 - 3 minutesmins - By Liza Laws

News and Trends 4 Aug 2022

New breast cancer treatment receives funding

Researchers at Queen’s University Belfast in Northern Ireland have received funding from Breast Cancer Now to search for new treatments inspired by COVID-19 vaccine innovation. The research team will adapt lessons from the development of COVID-19 vaccines in the hunt for new treatments for an aggressive form of breast cancer. Niamh Buckley and Helen McCarthy […]

August 4, 2022 - 3 minutesmins - By Jim Cornall

In Depth 3 Aug 2022

The biggest European biotech investments in July 2022

The mRNA firm Normax Biomed snagged Europe’s biggest private biotech investment in July 2022, with runners-up including AgomAb and Tropic Biosciences. Life sciences manufacturing companies saw a big windfall in Europe in July 2022 as the Cork-based Normax Biomed bagged around $301 million. The firm is establishing modular manufacturing facilities that could provide mRNA vaccines […]

August 3, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 2 Aug 2022

Sosei Heptares and AbbVie enter second collaboration targeting neurological diseases

A new drug discovery collaboration has taken place between Japanese Sosei Group Corporation and UK-based Abbvie with the hope of targeting neurological disease. This is the second partnership between the companies and offers the option to license agreement which is aimed at discovering, developing and commercializing small molecules that modulate novel G protein-coupled receptor (GPCR) […]

August 2, 2022 - 2 minutesmins - By Liza Laws

News and Trends 1 Aug 2022

Arecor Therapeutics adds diabetes product to portfolio after significant acquisition

Arecor Therapeutics plc has bought all of Tetris Pharma Ltd shares adding a key commercial diabetes product to its portfolio. The company says as well as expanding its portfolio, the acquisition of the entire issued share capital complements its existing hospital products franchise and will speed up its revenue growth. Injectable products Tetris Pharma has […]

August 1, 2022 - 3 minutesmins - By Liza Laws

cancer shutterstock immunotherapy deep science ventures

News and Trends 26 Jul 2022

Deep Science Ventures deepens CRUK pact to co-found oncology startups

The venture builder Deep Science Ventures (DSV) has expanded an existing alliance with Cancer Research UK’s innovation-focused arm Cancer Research Horizons, with the mission to establish new oncology startups in the U.K. Just months after Cancer Research UK (CRUK) established its industry-orientated division Cancer Research Horizons, the research charity has doubled down on a collaboration […]

July 26, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 26 Jul 2022

Oxford Biomedica sets up new project and signs LSA

Oxford Biomedica plc, a UK-based gene and cell therapy group, has initiated a new project with Orchard Therapeutics utilizing the company’s LentiStable technology. The group also announced the signing of a new licence and supply agreement (LSA) with an undisclosed US-based private biotech company advancing a new generation of adoptive cell therapies. LentiStable technology As […]

July 26, 2022 - 4 minutesmins - By Jim Cornall

sano genetics trial recruitment precision medicine

Opinion 25 Jul 2022

How to improve patient recruitment in your precision medicine research

Precision medicine research relies on genetic testing at scale, but has long suffered recruitment and retention headaches. The answer, says Patrick Short, CEO of Sano Genetics, is to start early and engage participants deeply. I witnessed first-hand the power of national scale genomics research through my PhD work analyzing genome sequence data from more than […]

July 25, 2022 - 7 minutesmins - By External Contributor

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

United Kingdom

Acquisition of TeneoTwo and its clinical-stage T-cell engager completed

How the UK precision breeding bill could unshackle gene editing

Research discovery may help diagnose and treat cancer and brain disorders

Start-up receives science and business support at Lab Hotel

PolyPid to receive millions for commercialization of infection-fighting drug

New breast cancer treatment receives funding

The biggest European biotech investments in July 2022

Sosei Heptares and AbbVie enter second collaboration targeting neurological diseases

Arecor Therapeutics adds diabetes product to portfolio after significant acquisition

Deep Science Ventures deepens CRUK pact to co-found oncology startups

Oxford Biomedica sets up new project and signs LSA

How to improve patient recruitment in your precision medicine research

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!